Cymbiotics Inc.

Cymbiotics is a pharmaceutical company with novel products for osteoarthritis, cardiovascular diseases, urinary incontinence,anti-aging, wound healing and other diseases. Cymbiotics products are IP protected and it uses well established large Pharmaceutical companies worldwide to distribute our products.

Activity:

- Clinical Trials
- Contract Manufacturing
- Contract Research
- Licensing & Business Development
- Manufacturing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- API / chemicals
- Cosmoceuticals
- Diagnostics
- FP (finished products)
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Phyto
- Preventive

Therapeutic targets:

- Aging
- Arthritis / Rheumato
- Cancer
- Cardiovascular
- Diabetes
- Mental Health
- Obesity
- Stroke
- Urology
- Women's Health

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: Africa , Asia , Central/South America , Far East , Near/Middle East , North America

c. Countries active: USA, Europe, South Africa, South Asia, Pacific Rim, South America

Corporate data:

Number of Employees: 19

Turnover:

Amount:	Year:	Currency:
20	2002	US Dollar

Year founded: 2003

Partners / Alliances: Dr. Reddys and Cipla are distribution partners for our Osteoarthritis products.